Clinical Trial Update: Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ (ZX-ZP-0055) [Phase 2]

View source ↗

Summary

The Phase 2 efficacy study evaluating ZuraPrep (ZX-ZP-0055) for preventing surgical site infections has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Surgical Site Infection

Drugs mentioned

• ZuraPrep

Snippet

Sponsor: Zurex Pharma, Inc. | Conditions: Surgical Site Infection | Phase 2 | Status: COMPLETED